Cite

HARVARD Citation

    Friedman, R. et al. (2011). Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban. Expert review of pharmacoeconomics & outcomes research. pp. 299-306. [Online]. 
  
Back to record